文献速递神经MR

连续使用大环类钆对比剂钆特酸葡胺与钆布醇对多发性硬化患者平扫T1加权脑部齿状核信号增高的影响:一项158例多发性硬化患者的回顾性研究

Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.
PubMed 文献 · Radiol Med · 2017-09-27

回顾性分析158例确诊多发性硬化患者,分别仅接受钆特酸葡胺(n=81)或钆布醇(n=77)连续增强检查,测量平扫T1WI齿状核与脑桥信号强度比值(DNP)。两组首末次MRI间DNP均增高(钆特酸葡胺0.0032±0.0216,钆布醇0.0019±0.0346),全人群差异无统计学意义;每组接受至少5次给药的患者中约三分之一可见齿状核T1高信号。作者认为连续使用大环类钆对比剂后出现的信号增高可能提示钆沉积。

要点

  • 连续使用钆特酸葡胺或钆布醇后,平扫T1WI齿状核信号可增高,可能提示钆沉积。
  • 每组接受至少5次给药的患者中约三分之一可见齿状核T1高信号。
  • 全人群首末次DNP变化差异无统计学意义。

核心结论

  • 连续使用大环类钆对比剂钆特酸葡胺和钆布醇后,平扫T1加权图像上的信号强度增高可能提示钆沉积。

研究设计与样本

  • 回顾性研究,经机构审查委员会批准并豁免知情同意,检索2007年3月1日至2016年7月31日PACS数据库,纳入158例确诊多发性硬化患者,仅接受钆特酸葡胺(n=81)或钆布醇(n=77)行诊断和随访。

关键影像表现/征象

  • 在齿状核和脑桥放置感兴趣区,测量平扫T1加权图像信号强度并计算齿状核-脑桥T1信号强度比值(DNP)。
  • 钆特酸葡胺组首末次MRI间DNP增高0.0032±0.0216,钆布醇组增高0.0019±0.0346。
  • 每组接受至少5次给药的患者中约三分之一可见齿状核T1高信号。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To perform T1 signal intensity (SI) measurements in the dentate nuclei of adult patients with confirmed multiple sclerosis (MS) after serial administrations of the macrocyclic gadolinium-based contrast agents (GBCAs), gadoterate meglumine and gadobutrol.

MATERIALS AND METHODS: This retrospective study was approved by the institutional review board and informed consent was waived. A review of our PACS database for the period from March 1, 2007 to July 31, 2016 revealed 158 confirmed MS patients who received exclusively either gadoterate meglumine (n = 81) or gadobutrol (n = 77) for diagnosis and follow-up. SI measurements on unenhanced T1-weighted images were performed on all scans of all patients and at regions of interest (ROIs) positioned on the dentate nucleus (DN) and pons. The dentate nucleus-to-pons (DNP) T1-SI ratio was subsequently calculated. Unpaired T test and regression analysis were used to evaluate statistical differences.

RESULTS: An increase in DNP was noted between the first and last MR examinations for both gadoterate meglumine (0.0032 ± 0.0216) and gadobutrol (0.0019 ± 0.0346). Although the differences were not statistically significant based across the entire patient population, visible T1 hyperintensity in the DN was noted in approximately one-third of all patients in each group that received at least five administrations of either GBCA.

CONCLUSIONS: SI increases on unenhanced T1-weighted images possibly indicative of gadolinium retention occur after serial administrations of the macrocyclic GBCAs, gadoterate meglumine and gadobutrol.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Splendiani A, Perri M, Marsecano C, et al. Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients. Radiol Med. 2017. PMID: 28952018. doi:10.1007/s11547-017-0816-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。